As U.S. COVID-19 cases rise, so does demand for antivirals
By Ahmed Aboulenein WASHINGTON -Rising COVID-19 cases are driving up the use of therapeutics, with Pfizer Inc’s oral antiviral treatment Paxlovid seeing a 315% jump over the past four weeks,…